GSA Capital Partners »

Diamedica Therapeutics shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Diamedica Therapeutics (DMAC) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Diamedica Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Diamedica Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Diamedica Therapeutics by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $110k 14k 7.93

More positions owned by GSA Capital Partners

Ishares Tr Fltg Rate Nt Etf (FLOT)
NVIDIA Corporation (NVDA)
Remitly Global (RELY)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Cheniere Energy Com New (LNG)
Mobileye Global Common Class A (MBLY)
EOG Resources (EOG)
Pfizer (PFE)
Match Group (MTCH)
Frontline (FRO)
Tutor Perini Corporation (TPC)
Delek Us Holdings (DK)
Allstate Corporation (ALL)
Microsoft Corporation (MSFT)
Costco Wholesale Corporation (COST)

View all positions for GSA Capital Partners

Top funds holding Diamedica Therapeutics

Omega Advisors
BlackRock
Millennium Management
Paragon Associates & Paragon Associates Ii Joint Venture
Geode Capital Management
Vanguard Group
State Street Corporation
First Manhattan
Bleichroeder
Northern Trust
Advisor Group Holdings
LPL Financial
Goldman Sachs Group
Bank of New York Mellon
Nuveen

View all funds holding Diamedica Therapeutics